Department of Dermatology, Referral center for toxic and auto-immune blistering diseases, Henri Mondor Hospital, Assistance Publique Hôpitaux de Paris Université Paris-Est Créteil, Créteil Cedex, F-94010, France.
Orphanet J Rare Dis. 2012 Sep 25;7:72. doi: 10.1186/1750-1172-7-72.
Severe cutaneous adverse reactions to drugs (SCARs) include acute generalized exanthematous pustulosis (AGEP), drug reaction with eosinophilia and systemic symptoms (DRESS) and epidermal necrolysis (Stevens-Johnson syndrome-toxic epidermal necrolysis [SJS-TEN]). Because of the varied initial presentation of such adverse drug reactions, diagnosis may be difficult and suggests overlap among SCARs. Overlapping SCARs are defined as cases fulfilling the criteria for definite or probable diagnosis of at least 2 ADRs according to scoring systems for AGEP, DRESS and SJS-TEN. We aimed to evaluate the prevalence of overlap among SCARs among cases in the referral hospital in France.
We retrospectively analyzed data for 216 patients hospitalized in the referral centre over 7 years with a discharge diagnosis of AGEP (n = 45), DRESS (n = 47), SJS-TEN (n = 80) or "drug rash" (n = 44). Each case with detailed clinical data and a skin biopsy specimen was scored for AGEP, DRESS and SJS-TEN by use of diagnostic scores elaborated by the RegiSCAR group.
In total, 45 of 216 cases (21%) had at least 2 possible diagnoses: 35 had a single predominant diagnosis (definite or probable), 7 had several possible diagnoses and 3 (2.1% of 145 confirmed SCARs) were overlap SCARs.
Despite ambiguities among SCARs, confirmed overlap cases are rare. This study did not avoid pitfalls linked to its retrospective nature and selection bias. In the acute stage of disease, early identification of severe ADRs can be difficult because of clinical or biologic overlapping features and missing data on histology, biology and evolution. Retrospectively analyzing cases by use of diagnostic algorithms can lead to reliable discrimination among AGEP, DRESS and SJS-TEN.
药物严重皮肤不良反应(SCARs)包括急性全身性发疹性脓疱病(AGEP)、药物反应伴嗜酸性粒细胞增多和全身症状(DRESS)和表皮坏死松解症(Stevens-Johnson 综合征-中毒性表皮坏死松解症 [SJS-TEN])。由于这些药物不良反应的初始表现多种多样,因此诊断可能较为困难,提示 SCARs 之间存在重叠。重叠性 SCARs 定义为根据 AGEP、DRESS 和 SJS-TEN 的评分系统,符合至少 2 种 ADR 明确或可能诊断标准的病例。我们旨在评估法国转诊医院中重叠性 SCARs 的患病率。
我们回顾性分析了 7 年来在转诊中心住院的 216 例患者的数据,这些患者的出院诊断为 AGEP(n=45)、DRESS(n=47)、SJS-TEN(n=80)或“药疹”(n=44)。使用 RegiSCAR 组制定的诊断评分对每个具有详细临床数据和皮肤活检标本的病例进行 AGEP、DRESS 和 SJS-TEN 评分。
共有 216 例病例中的 45 例(21%)存在至少 2 种可能的诊断:35 例有单一主要诊断(明确或可能),7 例有多种可能诊断,3 例(145 例确诊 SCARs 中的 2.1%)为重叠性 SCARs。
尽管 SCARs 之间存在歧义,但确诊的重叠病例很少。本研究并未避免其回顾性和选择偏倚带来的陷阱。在疾病的急性期,由于临床或生物学重叠特征以及组织学、生物学和演变方面的数据缺失,早期识别严重 ADR 可能较为困难。使用诊断算法对病例进行回顾性分析可可靠地区分 AGEP、DRESS 和 SJS-TEN。